San Rocco Therapeutics
  • Home
  • About SRT
    • Strategy
    • Team
  • Press & Publications
  • Rare & Orphan Diseases
    • Beta Thalassemia
    • For Patients
  • Science & Technology
    • Gene Therapy
    • Product Pipeline
      • Partnerships
      • CD47
      • TNS9
  • Contact
Select Page
Errant Gene Therapeutics becomes San Rocco Therapeutics

Errant Gene Therapeutics becomes San Rocco Therapeutics

by Giancarlo Girondi | May 5, 2021 | News

Errant Gene Therapeutics becomes San Rocco Therapeutics Errant Gene Therapeutics Becomes San Rocco Therapeutics twenty-eight years after its establishment. Errant Gene Therapeutics was founded in 1993, after founder Pat Girondi’s son was diagnosed with Thalassemia, a...
  • Home
  • About San Rocco Therapeutics
  • Press & Publications
  • Rare & Orphan Diseases
  • Science & Technology
  • Product Pipeline
  • Contact
© San Rocco Therapeutics 2023. All Rights Reserved. Website Designed by APOTH Creative. Sitemap